Optomed

Om

Optomed is a leading global provider of handheld fundus cameras and AI-powered screening software, listed on Nasdaq Helsinki and with products sold in over 60 countries. Their Aurora AEYE is the first FDA-cleared handheld AI fundus camera for autonomous diabetic retinopathy screening. With over 50 international patents and CE, FDA, and CFDA approvals, Optomed partners with major eye care companies to transform diagnostic eye care worldwide.